BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
241 hedge funds and large institutions have $5.87B invested in bluebird bio in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 81 increasing their positions, 78 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
-32
Holders Change %
-11.72%
% of All Funds
5.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
24
Increased
81
Reduced
78
Closed
54
Calls
$81.7M
Puts
$103M
Net Calls
-$21.7M
Net Calls Change
+$9.31M
Top Buyers
Top Sellers
1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$70.5M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$41.9M |
3 |
First Trust Advisors
Wheaton,
Illinois
|
-$37.1M |
4 |
Bank of America
Charlotte,
North Carolina
|
-$22.2M |
5 |
Goldman Sachs
New York
|
-$20.1M |